Product Program year 2024 Source: CMS Open Payments

Cytogam

Drug Infectious Disease

NDC 49591-532-51

Open in the dashboard

General payments

$83,396

128 payments

Research payments

$0

0 payments

Through program year 2024, $83,396 in general payments and $0 in research payments were reported against Cytogam (Infectious Disease).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2024 General $83,396 128

Breakdown

Who paid General payments · program year 2024
  1. Kamada Ltd. $83,396 128 payments
Top recipients General payments · program year 2024
  1. Sarah Sunshine Ophthalmology · Chicago, IL $23,200 28% · 1 payment
  2. Yoichiro Natori Infectious Disease · Miami, FL $8,120 10% · 9 payments
  3. Martin Zamora Critical Care Medicine · Orlando, FL $5,534 7% · 5 payments
  4. Lorenzo Zaffiri Pulmonary Disease · Atlanta, GA $5,381 6% · 9 payments
  5. Robert Gottlieb Advanced Heart Failure and Transplant Cardiology · Dallas, TX $5,328 6% · 3 payments

The top 5 of 49 recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Ophthalmology $23,200 28% · 1 practitioner
  2. Infectious Disease Internal Medicine $15,989 19% · 6 practitioners
  3. Pulmonary Disease Internal Medicine $12,876 15% · 6 practitioners
  4. Advanced Heart Failure and Transplant Cardiology Internal Medicine $9,309 11% · 7 practitioners
  5. Critical Care Medicine Internal Medicine $8,861 11% · 3 practitioners

The top 5 of 20 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. Illinois $23,258 28% · 3 recipients
  2. Florida $13,892 17% · 5 recipients
  3. Pennsylvania $8,338 10% · 7 recipients
  4. Texas $7,876 9% · 14 recipients
  5. California $6,672 8% · 7 recipients

The top 5 of 14 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

128 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record